Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “MITRAL VALVE”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 1,639 records · Page 91Linked to original sources
PubMed2004

Left ventricular rupture following mitral valve replacement due to oversize prosthesis.

Left ventricular rupture following mitral valve replacement is one of the most serious complications. We report our experience in successful treatment of type III left ventricular rupture following mitral valve replacement probably due to an oversize prosthesis. A 67-year-old woman, with the history of percutaneous transluminal mitral commissurotomy 11 years previously, underwent mitral valve replacement for mitral restenosis with a 27 mm CarboMedics mechanical bileaflet valve (Sulzer CarboMedics Inc., Austin, TX, U.S.A.). There were some difficulties in placing the entire prosthesis into the annulus at the posterior because of the oversize prosthesis. After the complete placement of the prosthesis, bulge of the left ventricular muscle was evident around the left lateral region. Following the cessation of cardiopulmonary bypass, type III left ventricular rupture, half a circular rip between the papillary muscles and posterior mitral annulus, occurred. The rip was suture-closed and a 23 mm CarboMedics valve was placed. Postoperative ultrasonic cardiography showed no prosthetic stenosis, periprosthetic leak, left ventricular pseudoaneurysm, nor left ventricular asynergy. Under cardioplegic arrest, we should not select the oversize prosthesis to prevent left ventricular rupture.

Aged↗
PubMed1993

[Ventricular fibrillation in a patient with mitral valve prolapse syndrome].

A patient with mitral valve prolapse who had cardiac arrest as a result of ventricular fibrillation is described. After two weeks of unconsciousness all brain functions gradually improved and full intellectual efficiency was regained. Exact study of the case did not reveal any other possible reason for ventricular fibrillation but mitral valve prolapse syndrome.

Adult↗
PubMed2004

[Short- and long-term follow-up of left ventricular function after surgical treatment of chronic mitral valve regurgitation].

UNLABELLED: There are conflicting data concerning late LV remodeling following mitral valve surgery due to chronic MR. We performed serial echocardiographic evaluation of 35 consecutive patients prior and following surgical treatment of mitral valve for chronic regurgitation. Studies were performed 1 week before operation (exam I), then at 1 week (exam II) and 9-13 months (exam III) (mean 11 months) after surgery. LVEDD and LVESD and LA size were recorded from parasternal long-axis view, and EF was calculated by Teichholtz formula. Statistical significance of achieved values was assessed. The study group consisted of 35 patients (25 males, 10 females, age 63 +/- 9 yrs). All pts were symptomatic due to the significant MR: NYHA II (n = 8), III (n = 25), IV (n = 2). All subjects had excluded coronary artery disease by coronary angiogram. 30 patients underwent successful mitral valve replacement without preservation of subvalvular apparatus and 5 mitral valve repair. Echo-Doppler examination before procedure discovered isolated significant MR (4+) with left ventricular dilatation (LVEDD 6.6 +/- 0.3 cm, LVESD 4.3 cm +/- 0.8), LA enlargement (6.0 +/- 1.1 cm), and pulmonary hypertension (systolic PAP 46 +/- 16 mmHg). After operation, marked decrease of LVEDD was observed (5.7 +/- 0.7 cm, p<0.0001 vs exam I) with only slight decrease of LVESD (4.0 +/- 0.6 cm, p<0.05 vs exam I) resulting in a significant decrease in EF (61 +/- 15.3% vs 57 +/- 4.8%, p<0.01). Significant reduction of LA size and PAP was noticed between exam I and III (6.0 +/- 1.1 cm vs 5.22 +/- 0.94 cm, p<0.0001, 46 +/- 16 mmHg vs 38 +/- 15 mmHg, p<0.01, respectively). CONCLUSIONS: After successful surgical treatment of mild-to-moderate symptomatic chronic MR there is a gradual fall of LVEDD implying continued ventricular remodeling over several months. However, we observed only a slight decrease of LVEDS with subsequent decrease of EF that may support the opinion of the crucial role of mitral valve apparatus in overall LV performance. EF fall did not preclude, however, reduction of pulmonary hypertension and LA diameter in long-term follow up.

Aged↗
PubMed1989

Generation of chordae tendineae with polytetrafluoroethylene stents. Results of mitral valve chordal replacement in sheep.

Surgical repair of ruptured or elongated chordae tendineae of the mitral valve is one of the most complex reconstructive techniques in cardiac surgery. Various surgical procedures have been described to repair chordal abnormalities of the anterior leaflet of the mitral valve with unpredictable results. Mitral valve replacement is usually recommended in that situation. This report describes a simple repair technique that we have devised. We resected one or two marginal chordae of the anterior leaflet of the mitral valve in 35 sheep and replaced them with a double-armed, pledget-supported, expanded polytetrafluoroethylene suture. The 30 surviving animals were studied hemodynamically and were electively put to death 3, 6, 9, 18, and 24 months after the operation. Mitral insufficiency did not develop in any of the sheep. All specimens had a normal mitral valve without thrombosis. The polytetrafluoroethylene suture remained pliable and was incorporated into the anterior leaflet and papillary muscle. Scanning and transmission electron microscopy showed that the suture was completely covered by a sheath of tissue with a collagen structure remarkably similar to that of a native chorda. Calcification was not detected in the new chordae. This reproducible and safe technique may considerably simplify the difficult repair of chordal abnormalities.

Animals↗
PubMed1994

The left atrial volume curve can be assessed from pulmonary vein and mitral valve velocity tracings.

After instantaneous left atrial volume was defined as the net difference between the forward-flowing blood from the lungs and the blood flowing through the mitral valve, we constructed the left atrial volume curve by sampling the Doppler mitral valve and the right upper pulmonary vein velocity from an apical four-chamber view in eight normal subjects and 11 patients with heart disease. The instantaneous mitral valve flow was estimated as mitral valve velocity x annular area (derived from the same view), whereas the pulmonary venous flow was obtained as right upper pulmonary vein velocity x pulmonary vein area, where pulmonary vein area = mitral valve velocity integral x mitral valve area) divided by pulmonary vein velocity integral. The left atrial volume curve can then be derived as: [(instantaneous pulmonary venous flow - mitral valve flow) + left atrial volume assessed at end diastole by two-dimensional echocardiography]. Biplane angiographic left atrial volume curves, available in four of 11 patients, compared morphologically very closely with the noninvasive curves, whereas the correlation coefficient for maximum (end-systolic) and filling (maximum minus minimum) left atrial volumes obtained from the Doppler-derived curve and the corresponding two-dimensional echocardiographic estimates was 0.95 (p < 0.001, standard error of the estimate = 11.9 ml), the dispersion of the data increased with decreasing volumes. These data demonstrate that combined Doppler mitral valve and pulmonary vein velocities can be used to construct the left atrial volume curve in human beings. The approach described, besides providing a tool for further noninvasive evaluation of the left atrial function, offers the opportunity for relating the continuous pulmonary venous flow to the intermittent filling of the ventricle through the mitral orifice in diastole, underlining the complex role that the left atrial cavity plays in this process.

Adolescent↗
PubMed1998

[Long-term results of mitral valve repair with artificial chordae tendineae].

The long-term results of mitral valve repair using artificial polytetrafluorethylene (PTFE) chordae were assessed in 61 consecutive patients with pure mitral regurgitation who underwent mitral valve repair with replacement of elongated or ruptured chordae tendineae between 1992 and 1996. There were 36 men and 25 women aged from 14 to 73 years (mean 52.1 +/- 13.8 years). The patients were followed up for between 1 to 73 months (mean 29.3 +/- 17.6 months). Fifty-five patients underwent mitral valve repair of the anterior leaflet and 6 repair of the posterior leaflet. There were two hospital and two late deaths. Actual survival rate at 5 years was 93.1%. Freedom from cardiac events at 5 years was 87.8%. Two patients required reoperation due to hemolysis. There were three occurrences of non-fatal thromboembolism. Although further investigation is necessary in a large population, expanded PTFE sutures are excellent for chordal replacement during mitral valve repair.

Adolescent↗
PubMed1999

Minimally invasive mitral valve surgery: mini-sternotomy with extended transseptal approach.

A partial upper sternotomy and an extended transseptal incision provide excellent exposure for mitral valve surgery. From March 1997 to December 1998, 462 patients had mitral valve surgeries using this minimally invasive approach. Eighty-seven percent had mitral valve repair, and 13% had mitral valve replacement. Thirteen patients (3%) required conversion to full sternotomy, and all other patients had the procedure completed using the initial approach. Forty-eight percent of patients were extubated within 6 hours of surgery, and 47% of patients spent less than 24 hours in the intensive care unit (ICU). Mean hospital length of stay was 7.2 +/- 5.4 days. Eighty-six percent of patients received no blood products. There was 1 hospital death (0.2%). Morbidity included reexploration for bleeding (4%), respiratory insufficiency (1%), stroke (1%), myocardial infarction (0.2%), and wound infection (0.2%). We conclude that virtually all mitral valve procedures, including complicated repairs, can be accomplished via partial upper sternotomy with an extended transseptal incision. This approach provides excellent exposure of the mitral valve and results in a low rate of wound complications, low transfusion requirements, and excellent cosmesis.

Adult↗
PubMed1989

Mitral valve prolapse: causes, clinical manifestations, and management.

PURPOSE: To assess the causes, methods of diagnosis, clinical spectrum, and management of mitral valve prolapse. DATA IDENTIFICATION: Results of prospective study of over 800 subjects at Cornell Medical Center from 1979 to the present were used along with studies published from 1963 to 1989 identified by computerized literature searches of Index Medicus and MEDLINE, and by hand searches. STUDY SELECTION: Studies involving controlled design, longitudinal follow-up, or critical assessment of diagnostic methodology, and clinical studies or previous reviews that have contributed most to the understanding of mitral valve prolapse were selected. DATA EXTRACTION: Data concerning the causes, clinical manifestations and complications, and prevalence of mitral valve prolapse, as well as the strength of association between mitral valve prolapse and diagnostic signs, were evaluated and used to develop a practical approach to evaluating and managing patients. RESULTS OF DATA SYNTHESIS: Most instances of mitral valve prolapse are primary and inherited, with possible genetic heterogeneity. Mitral prolapse may be diagnosed by auscultation of midsystolic clicks and late-systolic murmurs that respond typically to maneuvers, or by billowing of mitral leaflets across the mitral anular plane in long-axis, two-dimensional echocardiographic views or by a late-systolic, posterior leaflet displacement of at least 2 mm in meticulously targeted M-mode recordings. Mitral valve prolapse is associated with thoracic bony abnormalities, low body weight, low blood pressure, and a modest excess of orthostatic hypotension, syncope, palpitations, and atrial arrhythmias, but not with nonspecific symptoms (atypical chest pain, dyspnea, anxiety or panic attacks). Complications of mitral valve prolapse, including about 4000 mitral valve operations, 1100 cases of endocarditis, and possibly 4000 sudden deaths per year in the United States, are concentrated disproportionately in older men, with about 5% of affected men and 1.5% of affected women ultimately requiring valve surgery. CONCLUSIONS: Prophylaxis for endocarditis and closeness of follow-up should be related to the occurrence of the independent risk factors for complications of mitral prolapse (presence of mitral regurgitation, male gender, and age over 45 years), whereas active management and close observation are needed for severe mitral regurgitation and advanced ventricular arrhythmias.

Arrhythmias, Cardiac↗
PubMed1988

Mitral valve replacement in children.

Rheumatic fever leading to advanced valvular heart disease, in adults and children, is still frequently seen in developing countries. In the period 1981-87, 1137 patients underwent open heart surgery for either repair (489 patients), or replacement (639 patients) of defective cardiac valves. The experience with 75 children who underwent mitral valve replacement among this group is reviewed. The aetiology of mitral valve disease was rheumatic in 71, and infective endocarditis in four; 85% of the children were in NYHA functional class III, and 15% in class IV. Seven children had intra-operative findings of rheumatic activity. Pure mitral regurgitation was seen in 41, while mixed mitral valve disease was observed in 34 children. Twenty-seven children underwent mitral valve replacement with Ionescu-Shiley bovine pericardial valves, and 48 with mechanical Bi-leaflet valves. The operative mortality was 9.3%, and the actuarial survival rate, calculated by the Cutler and Ederers method, was 87% at 5 years.

Adolescent↗
PubMed1994

[True aneurysm of mitral valve secondary to aortic valvular infective endocarditis].

A case of the mitral valve aneurysm with aortic valvular infective endocarditis is reported. A 30-year-old male who had the history of Streptococcus viridans endocarditis underwent aortic and mitral valve replacement. The aortic valve was bicuspid and had the perforation in its non-coronary cusp, and histology in its specimen showed post-inflammatory vascularization and disorganization of architecture. A gigantic aneurysm was visible in the anterior leaflet of the mitral valve, but both anterior and posterior leaflets had no inflammatory change in histology. In this case, the "jet" of blood produced by aortic valve perforation involved the mitral valve. This aneurysmal change was so called "jet lesion" secondary to aortic valve endocarditis.

Adult↗
PubMed1999

[Ventricular fibrillation as a symptom of prosthetic valve dysfunction that was caused by thrombosis on mitral valve. Surgery or thrombolytic treatment?].

We discuss the case of 49 years old woman with recurrent thrombosis of prosthetic mitral valve with ventricular fibrillation as the complication. For the first time thrombotic prosthetic valve Carbo Medics 33 had been removed and the new valve--Medtronic Hall 31 mm was implanted in the mitral position. After diagnosis of the repeated thrombosis on the replaced prosthetic valve, the patient refused the subsequent operation. The fully effective thrombolytic therapy was then performed. The patient was discharged from the Department and was asymptomatic 4 month follow-up.

Coronary Thrombosis↗
PubMed1992

[A case report of primary rhabdomyosarcoma of the heart treated with mitral valve replacement].

We report a case of rhabdomyosarcoma involving the mitral valve of a 57-year-old female. She was referred to our hospital for progressive orthopnea and edema. Chest X-ray showed marked cardiomegaly and pulmonary congestion. Echocardiogram revealed solid mass in left atrium involving the mitral valve. Emergency operation was required because of acute heart failure. At the operation, the mitral orifice was obstructed by the tumor arising from the left atrium. After partial resection of the left atrium, mitral valve replacement with a Carpentier-Edward prosthesis was performed. Subsequently microscopic examination diagnosed as rhabdomyosarcoma. She died three months after the operation of heart failure probably due to progression of the remnant of the tumor. This, to our knowledge, is the first case of mitral valve replacement for a primary rhabdomyosarcoma of the heart in Japan.

Female↗
PubMed1995

Mitral valve replacement after previous right pneumonectomy.

Adequate exposure of the mitral valve is essential to the safe and effective performance of valve replacement. We describe a successful mitral valve replacement performed in a patient who had undergone a right pneumonectomy. After a median sternotomy was made, the mitral valve was approached through an incision in the left atrial appendage that extended to the origin of the left superior pulmonary vein. The operation was uncomplicated, and the patient made an uneventful recovery.

Aged↗
PubMed1990

Effects of standard mitral valve replacement on left ventricular function.

Recent studies have suggested that excision of the mitral valve apparatus during mitral valve replacement impairs left ventricular performance. However, functional measurements in humans have been difficult to obtain in a load-independent fashion. To investigate this concept, 12 patients (mean age, 65 +/- 8 years; mean New York Heart Association functional class, 3.3 +/- 0.7) with 4+ mitral regurgitation (n = 8) or mitral stenosis (valve area, 1.2 +/- 0.2 cm2) (n = 4) underwent prosthetic valve replacement using crystalloid cardioplegia. No patient required therapeutic inotropic support, every patient had at least the anterior mitral leaflet excised, and paced heart rate was maintained constant throughout. Left ventricular volume was measured with radionuclide angiocardiography, left ventricular pressure with a 3F micromanometer, and left ventricular wall volume with two-dimensional transesophageal echocardiography. Left ventricular preload was varied over a mean end-diastolic pressure range of 9 to 20 mm Hg and an end-diastolic volume range of 134 to 170 mL to generate four to five steady-state pressure-volume loops before and ten minutes after cardiopulmonary bypass. Left ventricular performance was estimated with the stroke work/end-diastolic volume relationship, which is insensitive to load. After bypass, no significant change (p greater than 0.1) was noted in wall volume for patients with mitral regurgitation or mitral stenosis (175 +/- 68 to 189 +/- 63 mL/m2 and 130 +/- 22 to 127 +/- 19 mL/m2, respectively).(ABSTRACT TRUNCATED AT 250 WORDS)

Aged↗
PubMed1990

Clinical and exercise echocardiographic findings in patients with mitral valve prolapse.

To assess the relationship between left ventricular functional reserve and prognosis in patients with idiopathic mitral valve prolapse, ergometer exercise echocardiography was performed in 10 normal subjects and 30 patients with mitral valve prolapse having either mild, or no mitral regurgitation. These 30 patients with mitral prolapse were followed for 2 to 8 (mean 4.5) years. Increment of % fractional shortening during maximum exercise at the initial study in patients with mitral valve prolapse and normal subjects were 7 +/- 7 and 11 +/- 3%, respectively. Based on increment of % fractional shortening, patients with mitral valve prolapse were divided into 2 groups; Group I: 13 cases with delta% fractional shortening less than 5%, Group II: 17 cases with delta% fractional shortening greater than or equal to 5%. The incidence of cardiac symptoms was higher in Group I than in Group II (85 vs 41%, p less than 0.05). ST-T changes and life-threatening arrhythmias were more frequently observed in Group I. During the follow-up period, M-mode echocardiographic measurements did not vary in Group II, but left ventricular and left atrial dimensions increased significantly (p less than 0.05, p less than 0.01, respectively) and % fractional shortening decreased significantly (p less than 0.01) in Group I without any change in mitral regurgitation severity. Thus, some patients with mitral valve prolapse not having significant mitral regurgitation may develop progressive deterioration of the cardiac function, which may be predicted by exercise echocardiography.

Adult↗
PubMed1963

Total replacement of the mitral valve: results of insertion of a Starr-Edwards valve in five patients.

In five patients the mitral valve was resected and total valve replacement undertaken. The Starr-Edwards prosthesis was inserted. The first patient died, two and one-half months after operation, of a wide massive left-atrial clot and peripheral embolization. The second and third patients are well and back at work at eight months after operation, and the fourth patient is well at two and one-half months after operation. The fifth patient died suddenly at three weeks from massive peripheral embolization originating from the left side of the heart. The technical details of the insertion of the valves are described and the importance of careful postoperative anticoagulant management is stressed.

Anticoagulants↗
PubMed2000

Mitral valve surgery and atrial fibrillation: is atrial fibrillation surgery also needed?

OBJECTIVE: Atrial fibrillation (AF) persisting after mitral valve surgery reduces survival due to heart failure and thrombo-embolisms, and impairs quality of life. Arrhythmia surgery for AF shows today very satisfying results and therefore mitral valve surgery with AF surgery appears appealing. This study explores whether combined surgery in view of today's results of mitral valve surgery is indicated. METHODS AND RESULTS: An outcome analysis of the arrhythmia outcome of patients undergoing exclusive mitral valve surgery with or without tricuspid repair was done. Preoperative baseline characteristics including arrhythmia pattern, surgical methods and follow-up findings were reviewed. Postoperative management of AF was not protocolized. Between 1990 and 1993, 162 consecutive patients underwent mitral valve surgery; follow-up was a mean of 3.3+/-1.9 years. In-hospital and late mortality were 1 and 9%, respectively. Sinus rhythm was preserved in 40 of 57 (70%) patients with preoperative sinus rhythm whereas AF persisted in 58 of 68 (85%) of patients with preoperative chronic AF (>1 year present). Sinus rhythm without AF was observed in 10 of 29 (34%) patients with preoperative paroxysmal AF. The 4-year Kaplan-Meier survival did not differ between patients with preoperative sinus rhythm (95.2%), paroxysmal AF (89.2%) and chronic AF (82.9%) but AF persisting after surgery tended to determine survival (P=0.05). Gender, age and right ventricular pressure and tricuspid valve repair were risk factors for postoperative recurrence of AF in patients with sinus rhythm at discharge, relative risk 0.35, 1.06, 1. 04 and 2.9, respectively. CONCLUSION: Current mitral valve surgery with or without tricuspid valve repair does not eliminate preoperative paroxysmal or chronic AF. Secondly, because preoperative AF did not determine survival after mitral valve surgery, whereas postoperatively persisting AF was weakly associated with survival, atrial arrhythmia surgery primarily aims to reduce morbidity due to AF. Some characteristics can identify patients with increased propensity for persisting AF after surgery. Randomized studies of AF surgery are needed to identify suitable candidates for combined surgery.

Adult↗